Quest Partners LLC Purchases New Shares in Embecta Corp. (NASDAQ:EMBC)

Quest Partners LLC acquired a new position in Embecta Corp. (NASDAQ:EMBC) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 16,925 shares of the company’s stock, valued at approximately $239,000.

Several other large investors also recently made changes to their positions in EMBC. CWM LLC lifted its position in shares of Embecta by 11.3% during the third quarter. CWM LLC now owns 10,102 shares of the company’s stock worth $142,000 after purchasing an additional 1,023 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of Embecta by 4.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,212 shares of the company’s stock valued at $278,000 after buying an additional 1,025 shares during the period. SummerHaven Investment Management LLC raised its position in shares of Embecta by 3.4% during the second quarter. SummerHaven Investment Management LLC now owns 36,198 shares of the company’s stock worth $452,000 after acquiring an additional 1,179 shares during the last quarter. Bayesian Capital Management LP lifted its stake in shares of Embecta by 13.3% during the first quarter. Bayesian Capital Management LP now owns 12,751 shares of the company’s stock valued at $169,000 after acquiring an additional 1,500 shares during the period. Finally, Ceera Investments LLC lifted its stake in shares of Embecta by 0.9% during the second quarter. Ceera Investments LLC now owns 178,353 shares of the company’s stock valued at $2,229,000 after acquiring an additional 1,514 shares during the period. Institutional investors own 93.83% of the company’s stock.

Embecta Trading Up 29.8 %

Shares of NASDAQ:EMBC opened at $18.70 on Wednesday. Embecta Corp. has a 1-year low of $9.93 and a 1-year high of $20.80. The stock has a market capitalization of $1.08 billion, a P/E ratio of 12.01 and a beta of 0.97. The business has a 50-day moving average price of $14.33 and a two-hundred day moving average price of $14.04.

Embecta Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Friday, December 6th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 3.21%. Embecta’s dividend payout ratio is currently 50.00%.

Embecta Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.